JR
Jyothi Reddy Lakkireddy
About Jyothi Reddy Lakkireddy
Data last updated:
Jyothi Reddy Lakkireddy is a Director at Gvr Pharma Private Limited (since 2013) and Director at Madhav Biotech Private Limited (since 2015). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹23.62 Cr; the largest is Gvr Pharma Private Limited at ₹23.62 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Dec 2013 | 2013 | ₹23.62 Cr (FY 2024) | Active | |
| Director | 25 Mar 2015 | 2006 | ₹14,809 (FY 2021) | Active |
Board colleagues of Jyothi Reddy Lakkireddy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lakkireddy Raja Krishna Reddy | 01255280 | Gvr Pharma Private Limited , Madhav Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jyothi Reddy Lakkireddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jyothi Reddy Lakkireddy
Jyothi Reddy Lakkireddy currently holds 2 directorships: Gvr Pharma Private Limited (Director, since 18 Dec 2013, revenue ₹23.62 Cr (FY 2024)); Madhav Biotech Private Limited (Director, since 25 Mar 2015, revenue ₹14,809 (FY 2021)).
Jyothi Reddy Lakkireddy was first appointed on 18 Dec 2013 as Director at Gvr Pharma Private Limited. The most recent appointment on record is 25 Mar 2015 at Madhav Biotech Private Limited.
The 2 current companies of Jyothi Reddy Lakkireddy that report revenue have a combined latest revenue of ₹23.62 Cr: Gvr Pharma Private Limited ₹23.62 Cr (FY 2024); Madhav Biotech Private Limited ₹14,809 (FY 2021).
The current boards of Jyothi Reddy Lakkireddy's companies include Lakkireddy Raja Krishna Reddy (Gvr Pharma Private Limited).